These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6100571)

  • 21. Mechanism of action of the antiviral compound MDL 20,610.
    Kenny MT; Torney HL; Dulworth JK
    Antiviral Res; 1988 Jul; 9(4):249-61. PubMed ID: 2849377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
    Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
    J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of in vitro and cell-mediated alteration of a human Rhinovirus and its inhibition by sodium dodecyl sulfate.
    Lonberg-Holm K; Noble-Harvey J
    J Virol; 1973 Oct; 12(4):819-26. PubMed ID: 4359954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds.
    Ahmad AL; Tyrrell DA
    Antiviral Res; 1986 Jul; 6(4):241-52. PubMed ID: 3017203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
    Conti C; Tomao P; Genovese D; Desideri N; Stein ML; Orsi N
    Antimicrob Agents Chemother; 1992 Jan; 36(1):95-9. PubMed ID: 1317152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of isoflavans and isoflavenes on rhinovirus 1B and its replication in HeLa cells.
    Conti C; Orsi N; Stein ML
    Antiviral Res; 1988 Nov; 10(1-3):117-27. PubMed ID: 2852916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
    Badger J; Minor I; Kremer MJ; Oliveira MA; Smith TJ; Griffith JP; Guerin DM; Krishnaswamy S; Luo M; Rossmann MG
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3304-8. PubMed ID: 2835768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral effect of hyperthermic treatment in rhinovirus infection.
    Conti C; De Marco A; Mastromarino P; Tomao P; Santoro MG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):822-9. PubMed ID: 10103186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
    Ledford RM; Collett MS; Pevear DC
    Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
    Mallamo JP; Diana GD; Pevear DC; Dutko FJ; Chapman MS; Kim KH; Minor I; Oliveira M; Rossmann MG
    J Med Chem; 1992 Dec; 35(25):4690-5. PubMed ID: 1335081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives.
    Garozzo A; Cutrì CC; Castro A; Tempera G; Guerrera F; Sarvà MC; Geremia E
    Antiviral Res; 2000 Mar; 45(3):199-210. PubMed ID: 10771083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
    Shepard DA; Heinz BA; Rueckert RR
    J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
    Conti C; Proietti Monaco L; Desideri N
    Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model for compounds active against human rhinovirus-14 based on X-ray crystallography data.
    Diana GD; Treasurywala AM; Bailey TR; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1990 May; 33(5):1306-11. PubMed ID: 2158559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
    Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
    Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel benzonitrile analogue inhibits rhinovirus replication.
    Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mode of action of 2-furylmercury chloride, an anti-rhinovirus compound.
    Verheyden B; Andries K; Rombaut B
    Antiviral Res; 2004 Mar; 61(3):189-94. PubMed ID: 15168800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.
    Zhang Y; Simpson AA; Ledford RM; Bator CM; Chakravarty S; Skochko GA; Demenczuk TM; Watanyar A; Pevear DC; Rossmann MG
    J Virol; 2004 Oct; 78(20):11061-9. PubMed ID: 15452226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds.
    Gruenberger M; Pevear D; Diana GD; Kuechler E; Blaas D
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():431-3. PubMed ID: 1847178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
    Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.